Why Cell and Gene Therapies Cost So Much – And What Can Be Done
Is Business Broken?
Pricing Paradigms of Cell and Gene Therapies
This chapter explores the complex pricing structures for cell and gene therapies, comparing them to bespoke goods due to their tailored nature and high development costs. It also discusses their potential long-term benefits and the challenges in evaluating their cost-effectiveness within a monopolistic market.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
